Kenneth Bartizal

Title: The Innovative Contributions of Kenneth Bartizal

Introduction

Kenneth Bartizal is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of fungal infections. With a total of six patents to his name, Bartizal's work has the potential to impact the medical community positively.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions and methods for the treatment of fungal infections." This patent features non-irritating pharmaceutical compositions containing CD101 in a pharmaceutical acceptable salt or neutral form, such as CD101 acetate. These compositions can be administered intravenously to treat fungal infections, including candidiasis. Another significant patent is focused on "Dosing regimens for treatment of fungal infections," which includes pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101 or its acceptable forms.

Career Highlights

Kenneth Bartizal has worked with prominent companies in the pharmaceutical industry, including Cidara Therapeutics, Inc. and Trius Therapeutics, Inc. His experience in these organizations has allowed him to develop innovative solutions for treating serious health conditions.

Collaborations

Throughout his career, Bartizal has collaborated with talented individuals such as Paul Daruwala and Voon Ong. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kenneth Bartizal's contributions to the field of pharmaceuticals, particularly in the treatment of fungal infections, demonstrate his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science and providing effective solutions for patients.